The Pharma Data

JANUARY 10, 2021

Based on its leading expertise in antibody, protein and peptide technologies, MorphoSys, together with its partners, has developed and contributed to the development of more than 100 product candidates, of which 27 are currently in clinical development.

Clinical Trials 52

Clinical Trials Clinical Development Clinical Supply Trials 52

LifeSciVC

AUGUST 21, 2024

An adverse event or serious adverse event (SAE) that turns out NOT to be related to the drug may take a while to sort out. I am fortunate to have a great Tech Ops team at Lifordi who is on top of managing all the moving parts across the globe for making tox and clinical supply for us.

Clinical Trials 72

Clinical Trials Trials Disease Treatment 72

The Pharma Data

JANUARY 24, 2021

Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases with the aim to obtain European Medicines Evaluation Agency and U.S. Food and Drug Administration (“FDA”) approval. References: Bailly, C.,

FDA 52

FDA Drugs Clinical Development Disease 52

The Pharma Data

OCTOBER 27, 2020

Under the agreement, during the option period, Molecular Partners will conduct Phase 1 clinical trials for MP0420, expected to begin in November 2020, and perform all remaining preclinical work for MP0423 and Novartis will conduct Phase 2 and Phase 3 clinical trials, with Molecular Partners as sponsor of these trials.

Therapies 40

Therapies Virus Treatment Clinical Trials 40

PPD

FEBRUARY 3, 2025

Critical focus areas to fast-track your clinical trials In the race to bring therapies to market faster, sponsors can gain a competitive edge by addressing three critical areas in their clinical development strategy: artificial intelligence (AI), integrated solutions, and site feasibility, selection and support.

Clinical Trials 52

Clinical Trials Trials Clinical Supply Drug Development 52